UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000049016
Receipt number R000055809
Scientific Title Randomised Controlled Trial of Meropenem versus Cefmetazole for definitive treatment of bloodstream infections due to ESBL- producing Escherichia coli
Date of disclosure of the study information 2022/09/26
Last modified on 2025/09/29 09:07:00

No. Disposal Last modified on Item of update
1 Insert 2022/09/26 12:53:39
2 Update 2022/09/26 14:56:50 Institutions
3 Update 2022/09/27 12:11:54 Key inclusion criteria
Key exclusion criteria
4 Update 2022/09/27 12:23:37 Key secondary outcomes
5 Update 2022/12/08 17:14:47 UMIN ID1
6 Update 2022/12/15 13:57:45 Recruitment status
Date of IRB
7 Update 2023/03/28 12:56:42 UMIN ID2
8 Update 2023/03/28 13:33:56 Institutions
9 Update 2023/08/02 14:10:45 Institutions
10 Update 2023/08/29 10:40:39 Email
Email
Name of person sending information
Name of person sending information
Email
11 Update 2023/08/29 10:54:02 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
12 Update 2023/09/26 09:30:25 Recruitment status
Other related information
Other related information
13 Update 2023/11/08 12:52:29 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
14 Update 2024/05/17 12:30:11 Institutions
15 Update 2024/05/17 12:34:42 Last follow-up date
16 Update 2024/08/30 09:00:55 UMIN ID3
17 Update 2024/08/30 11:00:33 Name of person sending information
Name of person sending information
Email
18 Update 2025/05/01 14:39:48 Organization
Organization
Email
Organization
Organization
Email
Organization
Organization
Email
Name of primary person or sponsor
Institute
Institute
Department
Organization1
Email1
Organization
Organization
Email
19 Update 2025/09/29 09:07:00 Recruitment status